Disclosure Plus

TiumBio Co., Ltd. Sells SK Plasma Stake for 9.3 Billion Won… 21.47% of Equity

kyoungeun kim
2026-09-30 16:23:40
[Edaily Reporter kyoungeun kim ] SK Plasma ( TiumBio Co., Ltd.(321550) ) announced on the 30th that it has decided to sell 240,000 shares of its common stock to SK Discovery for 9,259,900,000 won.

The disposal amount represents 21.47% of the company’s equity (43.12475 billion won). The disposal price per share is approximately 38,583 won. The scheduled disposal date is the 30th.

Following the sale, TiumBio Co., Ltd.’s holdings of SK Plasma shares will decrease to 426,667 shares, reducing its ownership stake to 2.71%. Prior to the sale, it held 666,667 shares.

The company stated that this decision was made to realize a confirmed profit through the disposal of investment assets and to secure funds for research and development.

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

“The Era of 1.5 Million Robots”… The Korean Company JP Morgan Has Singled Out

A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
2026-11-14 08:36:21